Comparison of Symptom Score, Urinary Flow Rate and Residual Urine :Transurethral Microwave Thermotherapy Versus Alpha-1 Blocker for Benign Prostatic Hyperplasia / 대한비뇨기과학회지

PURPOSE: We attempt to compare the impact of transurethral microwave thermotherapy (TUMT) with alpha-1 blocker (terazosin) on the symptom score, flow rate and residual urine. MATERIALS AND METHOD: A total of 29 patients underwent TUMT and 20 patients were treated by terazosin. FDA symptom score, urinary flow rate and residual urine before and after therapy were analyzed. RESULTS: Although an improvement in symptom score, flow rate and residual urine was noted at 6 months in both groups, there was no statistic significance between two groups in symptom score and flow rate. Reduction of residual urine only showed marginally significant difference in two groups. CONCLUSION: Except patients with absolute indications for transurethral resection of the prostate (TURP), those with symptomatic benign prostatic hyperplasia (BPH) will be benefited by these two modalities and TUMT is more effective than alpha-1 blocker in reducing residual urine.

Three Cases of Renal Infarction / 대한비뇨기과학회지

Renal Infarction is a rare disease and in 90% of patients with renal infarction, underlying cardiac disease is presented. Most often this includes valvular heart disease, cardiac arrhythmias, rheumatic heart disease with fibrillation, or subacute bacterial endocarditis. The correct clinical diagnosis and appropriate treatment of renal infarction are often delayed. Three cases of renal infarction were presented with review of literature.